Protein Biochips Market size is estimated to reach USD 36 Billion by the end of 2036, growing at a CAGR of 15% during the forecast period, i.e., 2023-2036. In the year 2023, the industry size of the protein biochips was around USD 8 Billion. The growth of the market can be attributed to the rising prevalence of chronic diseases, such as cancer which are increasing the demand for advanced diagnostic and therapeutic applications. As per the World Health Organization, nearly 10 million deaths in 2020 across the world were due to cancer. Protein biochips are small chips that contain proteins that can detect specific biomarkers associated with cancer.
Moreover, the advances in biochip technology, such as miniaturization and integration of sensors have enabled the development of more sensible and accurate protein biochips. There has been growing investment in research institutes that is expected to surge the need for protein biochips.
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
~15% |
|
Base Year Market Size (2022) |
~ USD 8 Billion |
|
Forecast Year Market Size (2035) |
~ USD 36 Billion |
|
Regional Scope |
|
Growth Drivers
Challenges
By Technology (Microarrays, Microfluidics)
The microarrays segment is estimated to hold 60% share of the global protein biochips market in the year 2036. The growth of the segment can be attributed to the increasing preference for microarrays owing to its ability to detect multiple biomarkers in a single assay, as well as its ability to generate higher throughput data compared to other technology-based protein biochips. Additionally, the rising demand for protein biochips for personalized medicine and drug discovery is also expected to contribute to the growth of the microarray segment. According to a study, there are 73,000 genetic testing products, and 250-300 personalized medicines that are currently available for cancer patients, genetic rare disease patients, and people with chronic and infectious diseases.
End-User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centres, Academic & Research Institutes)
By end-user segment, the biotechnology & pharmaceutical companies’ market is expected to gain growth of 35% by the year 2036. The growth of this segment can be attributed to the increasing number of biotechnology companies, growth in the biopharmaceutical Industry and, increasing numbers of clinical trials for the development of innovative medicines and treatments. According to the US National Library of Medicine, there are 446,246 clinical trials taking place in all 50 states and in 221 countries as of March 2023. Furthermore, the advancement in technology capabilities is also enabling the development of more targeted and precision medicine and treatments, further stimulating the growth of the segment.
Our in-depth analysis of the global market includes the following segments:
|
Technology |
|
|
End-User |
|
North American Market Forecast
The protein biochips market in North America is projected to be the largest with a share of about 38% by the end of 2036. The growth of the market can be attributed majorly to the growing awareness among healthcare professionals regarding the various advantages associated with protein biochips. This includes better accuracy, sensitivity, and specificity of the results, as well as their ability to provide quick and reliable results. Moreover, the lack of access to proper healthcare and nutrition, as well as the prevalence of unhealthy lifestyle choices, has caused a dramatic increase in the number of people suffering from chronic diseases such as diabetes, hypertension, and heart disease in the region. As reported by the Centers for Disease Control and Prevention CDC, in 2022, 6 out of 10 adults in the United States had a chronic illness, while 4 out of 10 adults had two or more chronic illnesses.
Asia Pacific Market Statistics
The Asia Pacific protein biochips market is estimated to be the second largest, registering a share of about 27% by the end of 2036. The growth of the market can be attributed majorly to the increasing health consciousness among people and rising awareness of the benefits of protein-based functional food and beverages are some of the major factors driving the growth of the market. Moreover, the rapid growth in life sciences research activities in India, and China supported by biotechnology and pharmaceutical research, and low infrastructure costs are significant factors driving the development of protein biochip market in the APAC region.
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?